🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Locally Advanced Pancreatic Cancer

Phase I/IIa Study: RR001 Administered Following Chemotherapy Cycles for Patients With Locally Advanced Pancreatic Carcinoma NCT06861452Phase 1, Phase 21 site📍 Modena EIR Biotherapies s.r.l. · Tests: RR001 Combined Chemotherapy And Ablative Radiotherapy (SBRT) As First-Line Treatment In Locally Advanced Inoperable Pancreatic Cancer (SBRT-PANC) NCT07407231NA1 site📍 Ljubljana Institute of Oncology Ljubljana · Tests: Ablative Stereotactic Body Radiotherapy (SBRT), Standard First-Line Chemotherapy Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer NCT06984562NA1 site📍 Philadelphia Fox Chase Cancer Center · Tests: Adaptive Radiation Therapy A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer NCT05365581Phase 146 sites📍 Orange📍 Santa Monica📍 Chicago Astellas Pharma Global Development, Inc. · Tests: ASP2138, Pembrolizumab, Oxaliplatin, Leucovorin, Fluorouracil Systemic Therapy With a Loco-regional Treatment in Patients With Locally Advanced Pancreatic Cancer NCT04276857NA2 sites📍 Regina📍 Saskatoon University of Saskatchewan · Tests: Irreversible electroporation (NanoKnife® ) Surgery for Locally Unresectable Pancreatic Cancer NCT07241663n/a1 site📍 Padova Azienda Ospedaliera di Padova · Tests: Questionnaire mFOLFIRINOX Plus Anlotinib and Sintilimab for Advanced Pancreatic Cancer NCT06761027Phase 1, Phase 24 sites📍 Fuzhou📍 Fuzhou📍 Fuzhou Fujian Provincial Hospital · Tests: Anlotinib combined with Sintilimab Standard or Prolonged Neoadjuvant Chemotherapy Before Surgery for BR/LAPC NCT06714604Phase 31 site📍 Gothenburg Sahlgrenska University Hospital · Tests: FOLFIRINOX or gemcitabine-nab-paclitaxel, FOLFIRINOX or gemcitabine-nab-paclitaxel A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors NCT07488676Phase 1, Phase 221 sites📍 Birmingham📍 Los Angeles📍 Miami Astellas Pharma Global Development, Inc. · Tests: ASP546C OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry. NCT04493632n/a9 sites📍 Las Palmas de Gran Canaria📍 Madrid📍 Madrid OncoSil Medical Limited Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer NCT06958328Phase 3333 sites📍 Gilbert📍 Gilbert📍 Peoria NRG Oncology · Tests: Biopsy Procedure, Biospecimen Collection, Capecitabine, Computed Tomography, Dose-escalated Radiation Therapy A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid Tumors NCT06500052Phase 11 site📍 Guangzhou Sichuan Baili Pharmaceutical Co., Ltd. · Tests: BL-M17D1 A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors NCT07229313Phase 17 sites📍 Santa Monica📍 New Have📍 Camperdown Kivu Bioscience Inc. · Tests: KIVU-107 A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors NCT07066657Phase 121 sites📍 Los Angeles📍 San Francisco📍 Aurora ArriVent BioPharma, Inc. · Tests: MRG007, MRG007 and Bevacizumab Prediction of Surgical Resectability After FOLFIRINOX Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: the Role of Diffusion Weighted Magnetic Resonance Imaging, Radiomics and Liquid Biopsy (PeRFormanCe Trial) NCT05298722NA8 sites📍 Ghent📍 Dendermonde📍 Eeklo University Hospital, Ghent · Tests: Imaging analysis of CT-scan and MRI with radiomics and genetic analysis of peripheral blood samples and questionnaires. Adebrelimab and Chidamide for Pancreatic Cancer NCT06584227Phase 21 site📍 Nanjing Liu Xiufeng · Tests: Adebrelimab and Chidamide Combined with Gemcitabine and S1 PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence Patients NCT06359275Phase 21 site📍 Shanhai Fudan University · Tests: PD-1, Nab-paclitaxel, Gemcitabine, PULSAR A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors NCT07094204Phase 120 sites📍 Santa Monica📍 Atlanta📍 Jefferson Astellas Pharma Inc · Tests: ASP5834, panitumumab IRE After Chemotherapy for Locally Advanced Pancreatic Cancer NCT07799935NA1 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: IRE, PLACEBO Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment NCT06574620NA1 site📍 Vancouver British Columbia Cancer Agency · Tests: Genetic testing, Optional biopsy, Tissue collection CT-guided Percutaneous Radionuclide Therapy With 32P Microparticles in Patients With Non-progressive Locally Advanced Pancreatic Cancer NCT07595835Phase 1, Phase 21 site📍 Amsterdam M.R. Meijerink · Tests: CT-guided percutaneous intratumoural implantation of the OncoSil™ device Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma NCT06582017Phase 111 sites📍 Los Angeles📍 Los Angeles📍 Los Angeles Nammi Therapeutics Inc · Tests: QXL138AM Injection every 2 weeks by IV Infusion SBRT Followed by Ipilimumab N01, Sintilimab, Nab-Paclitaxel and Gemcitabine for Locally Advanced Pancreatic Cancer NCT07683221Phase 21 site📍 Jinan Shandong Cancer Hospital and Institute · Tests: SBRT + Ipilimumab N01 + Sintilimab + AG Chemotherapy Stereotactic Body Radiotherapy and NALIRIFOX for Locally Advanced Pancreatic Cancer NCT07173387Phase 21 site📍 Jinan Shandong Cancer Hospital and Institute · Tests: NALIRIFOX (liposomal irinotecan-based chemotherapy)., Stereotactic Body Radiation Therapy (SBRT). Safety and Performance of a Novel Infusion Catheter System for Peri/Intratumoral Gemcitabine Delivery in Patients With Pancreatic Cancer NCT07575191Phase 1, Phase 21 site📍 Solna Smartwise Sweden AB · Tests: Gemcitabine, Extroducer Infusion Catheter System Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors NCT06545942Phase 118 sites📍 Goodyear📍 La Jolla📍 San Francisco MOMA Therapeutics · Tests: MOMA-313, Olaparib IRE Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy NCT07306273Phase 21 site📍 Shanghai Ruijin Hospital · Tests: Irreversible electroporation, Dual-Function Antibody PD-1/CTLA-4 Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Advanced Pancreatic Cancer NCT06755359NA12 sites📍 Bordeaux📍 Bordeaux📍 Clermont-Ferrand Alpha Tau Medical LTD. · Tests: Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer NCT06850623Phase 210 sites📍 Scottsdale📍 Stanford📍 Boston EXACT Therapeutics AS · Tests: Acoustic Cluster Therapy, Modified FOLFIRINOX EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors NCT07410676Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: EBNK-001 + IL-15 + Pembrolizumab
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy